Planned interruptions of anti-HIV treatment

This publication has 49 references indexed in Scilit:

• Anin VivoModel for HIV Resistance Development
  AIDS Research and Human Retroviruses, 2001
• Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
  Science, 2001
• Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination
  Science, 2000
• Changes in CD4 lymphocyte counts after interruption of therapy in patients with viral failure on protease inhibitor-containing regimens
  AIDS, 2000
• Strong Human Immunodeficiency Virus (HIV)–Specific CD4⁺T Cell Responses in a Cohort of Chronically Infected Patients Are Associated with Interruptions in Anti‐HIV Chemotherapy
  The Journal of Infectious Diseases, 2000
• Natural History of Human Immunodeficiency Virus Type 1 Viremia after Seroconversion and Proximal to AIDS in a Large Cohort of Homosexual Men
  The Journal of Infectious Diseases, 2000
• Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia
  AIDS, 2000
• Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype
  AIDS, 1999
• HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment
  AIDS, 1999
• Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
  The Journal of Experimental Medicine, 1995